KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesBeginning Cash BalanceCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Esperion Therapeutics (ESPR) Amortizatization of Intangibles: 2013-2023

Historic Amortizatization of Intangibles for Esperion Therapeutics (ESPR) over the last 11 years, with Dec 2023 value amounting to $412,000.

  • Esperion Therapeutics' Amortizatization of Intangibles rose 136.68% to $73,000 in Q2 2023 from the same period last year, while for Jun 2023 it was $505,000, marking a year-over-year increase of 232.89%. This contributed to the annual value of $412,000 for FY2023, which is 247.67% up from last year.
  • Esperion Therapeutics' Amortizatization of Intangibles amounted to $412,000 in FY2023, which was up 247.67% from -$279,000 recorded in FY2022.
  • Esperion Therapeutics' 5-year Amortizatization of Intangibles high stood at $412,000 for FY2023, and its period low was -$279,000 during FY2022.
  • Its 3-year average for Amortizatization of Intangibles is $40,333, with a median of -$12,000 in 2021.
  • Per our database at Business Quant, Esperion Therapeutics' Amortizatization of Intangibles tumbled by 2,225.00% in 2022 and then skyrocketed by 247.67% in 2023.
  • Esperion Therapeutics' Amortizatization of Intangibles (Yearly) stood at $200,000 in 2019, then slumped by 51.50% to $97,000 in 2020, then tumbled by 112.37% to -$12,000 in 2021, then plummeted by 2,225.00% to -$279,000 in 2022, then spiked by 247.67% to $412,000 in 2023.